Journal of Urologic Oncology

Complex Epidemiology of Prostate Cancer in Asian Countries (6,292 times) Kagenori Ito, Takahiro Kimura J Urol Oncol. 2023;21(1):5-13. Cited By 10 Review Article Mar 31, 2023 Full text PubReader ePub PDF	Current Update on Prostate Cancer Immunotherapy (4,173 times) Juliana E. Kim, Kunwoo Lee, Isaac Yi Kim J Urol Oncol. 2023;21(1):14-22. Review Article Mar 31, 2023 Full text PubReader ePub PDF
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023 (4,053 times) Jiwoong Yu, Hyun Hwan Sung J Urol Oncol. 2023;21(3):228-240. Cited By 2 Invited Review Nov 30, 2023 Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer Full text PubReader ePub PDF	Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type (3,846 times) Chan Woo Wee, Jaeho Cho J Urol Oncol. 2023;21(3):217-227. Cited By 2 Invited Review Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades (3,670 times) Sang Heon Han, Hyeong Dong Yuk J Urol Oncol. 2023;21(1):32-44. Cited By 11 Original Article Mar 31, 2023 The Landscape of Epidemiology in Urologic Cancers Full text PubReader ePub PDF Supplementary Material	Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up (3,625 times) Dong Gyun Kim, Ji Eun Heo, Kang Su Cho, et al. J Urol Oncol. 2023;21(1):70-78. Cited By 1 Original Article Mar 31, 2023 Full text PubReader ePub PDF
Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients (3,498 times) Stefani Frost, Parisa Ziarati, Ryan Moen, et al. J Urol Oncol. 2024;22(1):78-94. Cited By 1 Systemic Review and Meta-analysis Mar 31, 2024 Bladder Cancer Full text PubReader ePub PDF Supplementary Material	Genetic Testing for Prostate Cancer, Urothelial Cancer, and Kidney Cancer (3,401 times) Hyunho Han, Minyong Kang, Seok-Soo Byun, et al. J Urol Oncol. 2023;21(2):128-139. Cited By 1 Invited Review Jul 31, 2023 Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma Full text PubReader ePub PDF
The Current State and Future of Plasma Cell-Free DNA Analysis in Urologic Malignancies (3,355 times) Shusuke Akamatsu, Kei Mizuno, Takayuki Sumiyoshi, et al. J Urol Oncol. 2023;21(1):23-31. Cited By 1 Review Article Mar 31, 2023 Full text PubReader ePub PDF	Radical Cystectomy Versus Bladder-Preserving Therapy in Muscle-Invasive Bladder Cancer Patients After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Analysis (3,278 times) Youngheun Jo, Jun Seok Kim, Yoo Sub Shin, et al. J Urol Oncol. 2023;21(2):165-173. Cited By 1 Original Article Jul 31, 2023 Trimodality Therapy and Immuno-Oncology for Bladder Cancer Full text PubReader ePub PDF Supplementary Material
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy (3,150 times) Jin Hyuck Kim, Young Hwii Ko, Jong Wook Kim, et al. J Urol Oncol. 2023;21(1):79-87. Original Article Mar 31, 2023 Full text PubReader ePub PDF	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials (3,122 times) Sang Hun Song, Jong Jin Oh J Urol Oncol. 2023;21(2):154-164. Cited By 3 Invited Review Jul 31, 2023 Trimodality Therapy and Immuno-Oncology for Bladder Cancer Full text PubReader ePub PDF
The Future of Adjuvant Therapy in Renal Cell Carcinoma: Recent Insights and Prospects (3,055 times) Hyerim Ha, Joo Han Lim J Urol Oncol. 2023;21(3):208-216. Cited By 1 Invited Review Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review (2,897 times) Chang Wook Jeong J Urol Oncol. 2024;22(1):4-10. Cited By 3 Invited Review Mar 31, 2024 Prostate Cancer Full text PubReader ePub PDF
A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening (2,865 times) Jung Sik Huh, Kyung Kgi Park J Urol Oncol. 2023;21(2):121-127. Cited By 2 Original Article Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use (2,848 times) Byung Kwan Park J Urol Oncol. 2023;21(2):106-111. Cited By 3 Invited Review Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF
The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance (2,817 times) Chang Wook Jeong J Urol Oncol. 2023;21(2):97-105. Cited By 1 Invited Review Jul 31, 2023 mpMRI in the Management of Prostate Cancer: Role, Limitation, and Cost-Effectiveness Full text PubReader ePub PDF	Bladder Cancer in South Korea: Analysis of Trends and Risk Factors of Bladder Cancer in South Korea Using a Nationwide Database (2,806 times) Sangjun Yoo, Kyung-Do Han, Kwang Taek Kim, et al. J Urol Oncol. 2023;21(1):45-52. Cited By 1 Original Article Mar 31, 2023 Full text PubReader ePub PDF Supplementary Material
Contemporary Management of Small Renal Masses by Urologic Oncologists: A 2022 Korean Renal Cancer Study Group Practice Pattern Survey (2,741 times) Joongwon Choi, Cheryn Song, Jungyo Suh, et al. J Urol Oncol. 2023;21(1):59-69. Cited By 1 Original Article Mar 31, 2023 Full text PubReader ePub PDF	Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma (2,683 times) Sung Han Kim, Ilma S. Savul, Seth P. Lerner J Urol Oncol. 2024;22(1):68-77. Cited By 1 Invited Review Mar 31, 2024 Bladder Cancer Full text PubReader ePub PDF
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma (2,615 times) Edouard H. Nicaise, Benjamin N. Schmeusser, Yash B. Shah, et al. J Urol Oncol. 2023;21(3):183-199. Cited By 2 Invited Review Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF	Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis (2,612 times) Jin Noh, Sang Hun Song, Gyoohwan Jung, et al. J Urol Oncol. 2023;21(3):200-207. Cited By 1 Topic Article Nov 30, 2023 Perioperative Considerations and Treatment for Advanced Renal Cell Carcinoma Full text PubReader ePub PDF
Summarizing the Intentions and Outcomes of Journal of Urologic Oncology 2024 Issue 2 (2,567 times) Cheol Kwak J Urol Oncol. 2024;22(2):97-99. Editorial Jul 31, 2024 Full text PubReader ePub PDF	Korean Urologic Oncology Society Guidelines: Does Angioembolization Improve the Quality of Life for Renal Cell Carcinoma Patients With Intractable Symptoms Who Are Unfit for Surgery? (2,554 times) Ja Yoon Ku, Hui Mo Gu, Seong Hyeon Yu, et al. J Urol Oncol. 2023;21(2):140-147. Cited By 1 Invited Review Jul 31, 2023 Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma Full text PubReader ePub PDF Supplementary Material
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma (2,522 times) Dongsu Kim, Bumjin Lim, Jungyo Suh, et al. J Urol Oncol. 2023;21(2):148-153. Cited By 1 Original Article Jul 31, 2023 Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma Full text PubReader ePub PDF	Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer (2,498 times) Jaeyoung Cho, Jungyo Suh, Dalsan You, et al. J Urol Oncol. 2023;21(3):257-263. Cited By 1 Topic Article Nov 30, 2023 Clinical Predictors of ARTA Response in Metastatic Prostate Cancer Full text PubReader ePub PDF
Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review (2,471 times) Minseok Suh, Gi Jeong Cheon J Urol Oncol. 2024;22(1):11-20. Cited By 1 Invited Review Mar 31, 2024 Prostate Cancer Full text PubReader ePub PDF	The Use of 5-Alpha Reductase Inhibitors Improves the Detection of Prostate Cancer by Increasing Opportunities for Repeated Prostate-Specific Antigen Testing: A Decade-Long (2007–2016) Nationwide Observational Study in Korea (2,443 times) Young Hwii Ko, Sang Won Kim, Hoseob Kim, et al. J Urol Oncol. 2023;21(1):53-58. Original Article Mar 31, 2023 Full text PubReader ePub PDF
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy (2,412 times) Dan Bee Lee, Jae Yeon Kim, Yun Ha Lee, et al. J Urol Oncol. 2023;21(3):249-256.Correction in: 2024;22(2):183 Cited By 1 Original Article Nov 30, 2023 Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer Full text PubReader ePub PDF	Health Equity Research Outcomes and Improvement Consortium Prostate Cancer Health Precision Africa1K: Closing the Health Equity Gap Through Rural Community Inclusion (2,344 times) Vanessa M. Hayes, Sean M. Patrick, Joyce Shirinde, et al. J Urol Oncol. 2024;22(2):144-149. Cited By 2 Invited Review Jul 31, 2024 Prostate Cancer Full text PubReader ePub PDF

6,292	Complex Epidemiology of Prostate Cancer in Asian Countries
4,173	Current Update on Prostate Cancer Immunotherapy
4,053	Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
3,846	Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
3,670	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades

Cited By 11	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 10	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 3	The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By 3	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 3	Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review